Concepedia

Chong Si

CS

Statistics

Publications

8

Citations

686

H-Index

8

Active since

2010

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Eli Lilly (Spain)

Chong Si is an author at Eli Lilly (United States) specializing in pharmacology, natural sciences, and medicinal chemistry.

Top concepts

PharmacologyMedicineNatural SciencesMedicinal ChemistryBiochemistryTumor BiologyDrug DiscoveryPharmacotherapyMolecular OncologyBioorganic Chemistry

Publications per year

2010–2021

8

Publications

8

Mediator kinase inhibition further activates super-enhancer-associated genes in AML

Henry E. Pelish, Brian B. Liau, I Niţulescu et al. · Nature · 2015 · 391 citations · Full text

Mediator Kinase Inhibition, Transcriptional Regulation, Signal Transduction +5

Synthesis of cortistatins A, J, K and L

Alec N. Flyer, Chong Si, Andrew G. Myers · Nature Chemistry · 2010 · 92 citations · Full text

Bioorganic Chemistry, Cortistatins A, Pharmacology +2

A Versatile Synthesis of Substituted Isoquinolines

Chong Si, Andrew G. Myers · Angewandte Chemie International Edition · 2011 · 55 citations

Investigation of resistance levels and mechanisms to nicosulfuron conferred by non-target-site mechanisms in large crabgrass (Digitaria sanguinalis L.) from China

Mei Yu, Chong Si, Mingjie Liu et al. · Pesticide Biochemistry and Physiology · 2016 · 41 citations

Biology, Resistance Levels, Botany +8

Abstract 1259: Preclinical characterization of LY3537982, a novel, highly selective and potent KRAS-G12C inhibitor

Sheng-Bin Peng, Chong Si, Youyan Zhang et al. · Cancer Research · 2021 · 41 citations

Drug Target, Molecular Biology, Pharmacotherapy +23

1–5 of 8